These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 24809946

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 - Part I.
    Bailey JJ, Schirrmacher R, Farrell K, Bernard-Gauthier V.
    Expert Opin Ther Pat; 2017 Jun; 27(6):733-751. PubMed ID: 28270010
    [Abstract] [Full Text] [Related]

  • 4. Tropomyosin receptor kinase inhibitors: an updated patent review for 2016-2019.
    Bailey JJ, Jaworski C, Tung D, Wängler C, Wängler B, Schirrmacher R.
    Expert Opin Ther Pat; 2020 May; 30(5):325-339. PubMed ID: 32129124
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Type II & III inhibitors of tropomyosin receptor kinase (Trk): a 2020-2022 patent update.
    Iliev P, Jaworski C, Wängler C, Wängler B, Page BDG, Schirrmacher R, Bailey JJ.
    Expert Opin Ther Pat; 2024 Apr; 34(4):231-244. PubMed ID: 38785069
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Discovery of Potent, Selective, and Peripherally Restricted Pan-Trk Kinase Inhibitors for the Treatment of Pain.
    Bagal SK, Andrews M, Bechle BM, Bian J, Bilsland J, Blakemore DC, Braganza JF, Bungay PJ, Corbett MS, Cronin CN, Cui JJ, Dias R, Flanagan NJ, Greasley SE, Grimley R, James K, Johnson E, Kitching L, Kraus ML, McAlpine I, Nagata A, Ninkovic S, Omoto K, Scales S, Skerratt SE, Sun J, Tran-Dubé M, Waldron GJ, Wang F, Warmus JS.
    J Med Chem; 2018 Aug 09; 61(15):6779-6800. PubMed ID: 29944371
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers.
    Jiang T, Wang G, Liu Y, Feng L, Wang M, Liu J, Chen Y, Ouyang L.
    Acta Pharm Sin B; 2021 Feb 09; 11(2):355-372. PubMed ID: 33643817
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of WO2015042088 A1 - a novel urea-based scaffold for TrkA inhibition.
    Bernard-Gauthier V, Schirrmacher R.
    Expert Opin Ther Pat; 2016 Feb 09; 26(2):291-5. PubMed ID: 26561352
    [Abstract] [Full Text] [Related]

  • 15. p21-Activated kinase inhibitors: a patent review.
    Crawford JJ, Hoeflich KP, Rudolph J.
    Expert Opin Ther Pat; 2012 Mar 09; 22(3):293-310. PubMed ID: 22404134
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Aurora kinase inhibitor patents and agents in clinical testing: an update (2011 - 2013).
    Cheung CH, Sarvagalla S, Lee JY, Huang YC, Coumar MS.
    Expert Opin Ther Pat; 2014 Sep 09; 24(9):1021-38. PubMed ID: 24965505
    [Abstract] [Full Text] [Related]

  • 19. The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of Pain.
    Skerratt SE, Andrews M, Bagal SK, Bilsland J, Brown D, Bungay PJ, Cole S, Gibson KR, Jones R, Morao I, Nedderman A, Omoto K, Robinson C, Ryckmans T, Skinner K, Stupple P, Waldron G.
    J Med Chem; 2016 Nov 23; 59(22):10084-10099. PubMed ID: 27766865
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.